2023
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure
Christian N, Zhou X, Radhakrishnan R. Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure. JAMA Psychiatry 2023, 80: 968-968. PMID: 37405794, DOI: 10.1001/jamapsychiatry.2023.2113.Peer-Reviewed Original ResearchMeSH KeywordsCOVID-19HumansOutcome Assessment, Health CareStress Disorders, Post-TraumaticSubstance-Related Disorders
2022
Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study.
Ramakrishnan D, Sureshanand S, Pittman B, Radhakrishnan R. Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study. The Journal Of Clinical Psychiatry 2022, 83 PMID: 36044600, DOI: 10.4088/jcp.21m14332.Peer-Reviewed Original ResearchMeSH KeywordsAlcoholismBenzodiazepinesCannabisCocaineCOVID-19HallucinogensHumansOpioid-Related DisordersRetrospective StudiesSubstance-Related DisordersConceptsCOVID-19 outcomesSubstance use disordersOpioid use disorderCOVID-19 patientsAlcohol use disorderRetrospective cohort studyVentilatory supportICU admissionUse disordersHospital admissionPsychiatric diagnosisCohort studyIntensive care unit admissionCOVID-19 positive patientsCare unit admissionLength of hospitalizationLarge health care systemMultivariable logistic regressionHigh-risk groupNumber of hospitalizationsBenzodiazepine use disorderCannabis use disorderUrine toxicology reportsElectronic medical recordsCocaine use disorder